RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma

BACKGROUND: Adoptive T-cell therapy relying on conventional T cells transduced with T-cell receptors (TCRs) or chimeric antigen receptors (CARs) has caused substantial tumor regression in several clinical trials. However, genetically engineered T cells have been associated with serious side-effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrer, Dennis C., Simon, Bianca, Fujii, Shin-ichiro, Shimizu, Kanako, Uslu, Ugur, Schuler, Gerold, Gerer, Kerstin F., Hoyer, Stefanie, Dörrie, Jan, Schaft, Niels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561563/
https://www.ncbi.nlm.nih.gov/pubmed/28818060
http://dx.doi.org/10.1186/s12885-017-3539-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561563/
https://www.ncbi.nlm.nih.gov/pubmed/28818060
http://dx.doi.org/10.1186/s12885-017-3539-3

Ejemplares similares